A breakthrough human trial achieved highly statistically-significant results and an excellent safety record, demonstrating that MDMA-assisted therapy can be an effective treatment for severe and chronic Post-Traumatic Stress Disorder (PTSD). At the end of the randomized, blinded, Phase 3 trial, carried out by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), 67% of participants who […]

The post Phase 3 Trial of MDMA Therapy for Severe PTSD is So Successful That 67% Don’t Qualify For Diagnosis Now appeared first on Good News Network.